These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3623244)

  • 1. Intensive care therapy for patients with hematological diseases.
    Anger B; Schmeiser T; Sigel H; Heimpel H
    Haematol Blood Transfus; 1987; 30():519-23. PubMed ID: 3623244
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcome of critically ill patients with hematological malignancies: what's next?
    Soubani AO; Decruyenaere J
    Intensive Care Med; 2014 Sep; 40(9):1377-80. PubMed ID: 25082360
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic issues in the ICU.
    Parker RI
    Crit Care Clin; 2012 Jul; 28(3):ix-x. PubMed ID: 22713618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Survival and analysis of prognostic indices in patients with hematologic diseases treated in an intensive care unit].
    Arranz Sáez R; López Messa JB; Sánchez García M; Alonso P; González Gómez N; Solano Vercet C; Montalvo Burbano M; Torres Moldenhauer T; Fernández-Rañada JM
    Med Clin (Barc); 1986 May; 86(17):709-11. PubMed ID: 3736160
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematologic problems in the ICU.
    Crit Care Nurs Q; 1990 Sep; 13(2):v-vi, 1-82. PubMed ID: 2383779
    [No Abstract]   [Full Text] [Related]  

  • 6. International Meeting on the Therapy of Hematological Malignancies in the Elderly. Proceedings. Turin, 15-16 April 1993.
    Hematol Oncol; 1993; 11 Suppl 1():1-84. PubMed ID: 8486335
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of blood diseases in a specialized department].
    Beran M; Carlmark B; Ehn L; Ericsson F; Forsberg K; Hast R; Höglund S; Lantz B; Pihlstedt P; Reizenstein P; Skårberg KO; Udén AM; Osby E
    Lakartidningen; 1980 Apr; 77(17):1635-9. PubMed ID: 6770206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood component therapy in hematological diseases].
    Abdulkadyrov KM
    Klin Med (Mosk); 1994; 72(2):10-3. PubMed ID: 8015232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognosis of the hematologic patients admitted to an Intensive Care Unit].
    Ferrà C; Ribera JM
    Med Clin (Barc); 2012 Dec; 139(14):631-3. PubMed ID: 22944211
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and outcomes of haematology patients admitted to the intensive care unit.
    McCaughey C; Blackwood B; Glackin M; Brady M; McMullin MF
    Nurs Crit Care; 2013 Jul; 18(4):193-9. PubMed ID: 23782113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.
    Bokhari SW; Munir T; Memon S; Byrne JL; Russell NH; Beed M
    Ann Hematol; 2010 May; 89(5):505-12. PubMed ID: 19876629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to look beyond one-year mortality in critically ill hematological patients?
    Moors I; Benoit DD
    Crit Care; 2014 Feb; 18(1):107. PubMed ID: 24517551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the nurse in the bone marrow unit.
    O'Leary S
    World Ir Nurs; 1985; 4(3):5-6. PubMed ID: 3895757
    [No Abstract]   [Full Text] [Related]  

  • 14. [A system of training mid-level health personnel for work in the intensive hematologic care unit].
    Bláha M; Vanásek J; Pidrman V; Brandová J
    Vnitr Lek; 1983 Oct; 29(10):1003-10. PubMed ID: 6649448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Supervision of the treatment of malignant hemopathies].
    DEBRAY JM
    Sem Hop Ther Paris; 1962 May; 38():438-9. PubMed ID: 13884695
    [No Abstract]   [Full Text] [Related]  

  • 16. [On chemotherapy of hemoblastoses and malignant tumors].
    LINKE A; FREUDENBERGER B
    Probl Symp Aktuell Ther; 1960; 3():38-134. PubMed ID: 13762454
    [No Abstract]   [Full Text] [Related]  

  • 17. Marrow transplantation and gene transfer as therapy for hematopoietic diseases.
    Thomas ED
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1009-12. PubMed ID: 3555976
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.
    Cherif H; Martling CR; Hansen J; Kalin M; Björkholm M
    Support Care Cancer; 2007 Dec; 15(12):1393-8. PubMed ID: 17516092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences of dispensary care of patients with hematologic diseases].
    Runge A
    Z Arztl Fortbild (Jena); 1968 Jan; 62(1):40-2. PubMed ID: 4973206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood component and infusion-detoxification therapy of patients with hematologic diseases].
    Abdulkadyrov KM; Shcherbakova EG; Ganapiev AA
    Gematol Transfuziol; 1984 Sep; 29(9):3-9. PubMed ID: 6519428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.